QSS
ABUS icon

Quantitative Systematic Strategies’s Arbutus Biopharma ABUS Stock Holding History

Quantitative Systematic Strategies’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-18,404
Closed -$217K – 351
2015
Q2 		$217K Sell
18,404
-3,184
-15% -$48.5K 0.05% 459
2015
Q1 		$382K Buy
+21,588
New +$442K 0.1% 303

Other funds holding ABUS

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Quantitative Systematic Strategies's ABUS Position: Q3 2015 in Review

Quantitative Systematic Strategies sold out of Arbutus Biopharma (ABUS) in Q3 2015, closing a stake of 18,404 shares — an estimated $217K sold.

Quantitative Systematic Strategies first reported a position in ABUS in Q1 2015 and held it in 2 quarters. The position peaked at $382K in Q1 2015. 55 funds tracked by Wall St. Rank hold ABUS as of Q3 2015.

  • Quantitative Systematic Strategies reported no remaining Arbutus Biopharma position as of Q3 2015 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 18,404 Arbutus Biopharma shares in Q3 2015, an estimated $217K.
  • Quantitative Systematic Strategies first reported a position in Arbutus Biopharma in Q1 2015 and held it in 2 quarters.
  • Quantitative Systematic Strategies's Arbutus Biopharma position peaked at $382K in Q1 2015.
  • 55 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2015.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2015, filed 30 Oct 2015.